Showing 1,061 - 1,080 results of 1,661 for search '"biomedical science"', query time: 0.08s Refine Results
  1. 1061
  2. 1062
  3. 1063
  4. 1064
  5. 1065
  6. 1066
  7. 1067
  8. 1068
  9. 1069
  10. 1070
  11. 1071
  12. 1072
  13. 1073
  14. 1074
  15. 1075
  16. 1076

    Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study by Mizoguchi Y, Hino M, Ueda H, Miyaguchi Y, Kobayashi M

    Published 2025-01-01
    “…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
    Get full text
    Article
  17. 1077

    Review of Challenges in Performing Real-World Evidence Studies for Nonprescription Products by Maihöfner C, Mallick-Searle T, Vollert J, Kalita P, Sood Sethi V

    Published 2025-01-01
    “…Christian Maihöfner,1 Theresa Mallick-Searle,2 Jan Vollert,3 Pranab Kalita,4 Vidhu Sood Sethi5 1Department of Neurology, General Fürth Hospital, University of Erlangen, Fürth, Germany; 2Division of Pain Medicine, Stanford Health Care Pain Management Clinic, Palo Alto, CA, USA; 3Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK; 4Global Category Medical Affairs, Haleon Plc, Weybridge, England, UK; 5Global Medical Affairs, GSK Consumer Healthcare Singapore Pte. …”
    Get full text
    Article
  18. 1078
  19. 1079
  20. 1080